This is a demo store. No orders will be fulfilled.

APX-115 - 99%, high purity , CAS No.1395946-75-4

    Grade & Purity:
  • ≥99%
In stock
Item Number
A650330
Grouped product items
SKU Size
Availability
Price Qty
A650330-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$150.90
A650330-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$250.90
A650330-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$500.90
A650330-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$750.90

Basic Description

Synonyms 1H-Pyrazol-5-ol, 3-phenyl-4-propyl-1-(2-pyridinyl)-, hydrochloride (1:1) | HY-120801 | 1395946-75-4 | Apx 115 | Q99G5ZE5U5 | APX 115 [WHO-DD] | Isuzinaxib hydrochloride | SCHEMBL15610231 | UNII-Q99G5ZE5U5 | 5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-on
Specifications & Purity ≥99%
Biochemical and Physiological Mechanisms APX-115 (Ewha-18278) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with K i values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1 , Nox2 and Nox4 , respectively. APX-115 effectively prevents kidney injury.
Storage Temp Store at 2-8°C,Desiccated
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

APX-115 (Ewha-18278) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with K i values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1 , Nox2 and Nox4 , respectively. APX-115 effectively prevents kidney injury

In Vitro

APX-115 (5?μM; 60?min) almost completely suppresses high glucose-induced proinflammatory and profibrotic molecule expression in the mouse podocyte cell line. ?\nIn the kidney, APX-115 attenuates Nox gene upregulation and protein expression while improving inflammatory and fibrotic processes. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

APX-115 (oral gavage; 60?mg/kg/day; for 12 weeks) significantly improves insulin resistance in diabetic mice. ?\nAPX-115 treatment decreases the urinary excretion of albumin and plasma creatinine levels. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six-week-old male diabetic db/db mice (C57BLKS/J- lepr db /lepr db )Dosage: 60 mg/kg Administration: Oral gavage; per day; for 12 weeks Result: Significantly improved insulin resistance in diabetic mice.

Form:Solid

IC50& Target:NOX1 NOX2 NOX4

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Pyridines and derivatives
Subclass Pyrazolylpyridines
Intermediate Tree Nodes Not available
Direct Parent Pyrazolylpyridines
Alternative Parents Methylpyridines  Benzene and substituted derivatives  Vinylogous amides  Pyrazolines  Pyrazoles  Heteroaromatic compounds  Lactams  Propargyl-type 1,3-dipolar organic compounds  Carboxylic acids and derivatives  Azacyclic compounds  Aldimines  Organopnictogen compounds  Organooxygen compounds  Organic oxides  Hydrochlorides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteromonocyclic compounds
Substituents 2-pyrazolylpyridine - Methylpyridine - Benzenoid - Monocyclic benzene moiety - Heteroaromatic compound - Vinylogous amide - Pyrazoline - Pyrazole - Azole - Lactam - Azacycle - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Carboxylic acid derivative - Aldimine - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Hydrochloride - Organooxygen compound - Organonitrogen compound - Imine - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as pyrazolylpyridines. These are compounds containing a pyrazolylpyridine skeleton, which consists of a pyrazole linked (not fused) to a pyridine by a bond.
External Descriptors Not available

Names and Identifiers

IUPAC Name 5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one;hydrochloride
INCHI InChI=1S/C17H17N3O.ClH/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15;/h3-7,9-12,19H,2,8H2,1H3;1H
InChIKey YEEIHSUMLNXRMI-UHFFFAOYSA-N
Smiles CCCC1=C(NN(C1=O)C2=CC=CC=N2)C3=CC=CC=C3.Cl
Isomeric SMILES CCCC1=C(NN(C1=O)C2=CC=CC=N2)C3=CC=CC=C3.Cl
Alternate CAS 1395946-75-4
PubChem CID 60172240
MeSH Entry Terms 3-phenyl-1-(pyridin-2-yl)-4-propyl-1H-5-hydroxypyrazole HCl;3-phenyl-4-propyl-1-(2-pyridinyl)-1H-pyrazol-5-ol;3-phenyl-4-propyl-1-(2-pyridinyl)-1H-pyrazol-5-ol hydrochloride;APX-115;APX-115 free base;Ewha-18278;EWHA-18278 free base;isuzinaxib;isuzinaxib h
Molecular Weight 315.80

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Solubility DMSO : 100 mg/mL (316.66 mM; Need ultrasonic)
Molecular Weight 315.800 g/mol
XLogP3
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 4
Exact Mass 315.114 Da
Monoisotopic Mass 315.114 Da
Topological Polar Surface Area 45.200 Ų
Heavy Atom Count 22
Formal Charge 0
Complexity 412.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 2

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.